Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Japanese Biotech Firm Edigene Raises $14.4M In Series B
LPNEWS

Japanese Biotech Firm Edigene Raises $14.4M In Series B

by dealstreetasia.com posted 3months ago 14 views
EdiGENE is an emerging biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM. The post Japanese biotech firm EdiGENE raises $14.4m in Series B appeared first on DealStreetAsia.

In this article